Sale!

RPL26 Gene Diamond-Blackfan Anemia Type 11 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “RPL26 Gene Diamond-Blackfan Anemia Type 11 Genetic Test” is a specific diagnostic tool used to identify mutations in the RPL26 gene, which are linked to Diamond-Blackfan Anemia (DBA) Type 11. DBA is a rare, inherited bone marrow failure disorder characterized by an inability to produce red blood cells, leading to severe anemia and various congenital abnormalities. The test plays a crucial role in confirming the diagnosis of DBA Type 11, enabling targeted treatment strategies and genetic counseling for affected families.

Performed at DNA Labs UAE, this genetic test involves analyzing the patient’s DNA to search for mutations in the RPL26 gene that are known to cause the condition. The test cost is set at 4400 AED, reflecting the specialized nature of the testing process and the expertise required to accurately interpret the results. By providing a definitive diagnosis, the test allows healthcare providers to tailor treatment plans to the specific needs of the patient, potentially improving outcomes and quality of life for those affected by this rare genetic disorder.

Description

RPL26 Gene Diamond-Blackfan Anemia Type 11 Genetic Test

Test Name: RPL26 Gene Diamond-Blackfan anemia type 11 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RPL26 Gene Diamond-Blackfan anemia type 11 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RPL26 Gene Diamond-Blackfan anemia type 11 NGS Genetic DNA Test gene RPL26

Test Details: The RPL26 gene is a gene that provides instructions for making a protein called ribosomal protein L26. This protein is a component of the ribosome, which is the cellular machinery responsible for protein synthesis. Diamond-Blackfan anemia (DBA) is a rare genetic disorder characterized by a failure of the bone marrow to produce red blood cells. It is usually diagnosed in infancy or early childhood and can lead to symptoms such as pale skin, fatigue, and an increased risk of infections.

NGS (Next-Generation Sequencing) genetic testing is a technique that allows for the simultaneous sequencing of multiple genes or even the entire genome. It can be used to identify genetic mutations or variations that may be associated with a particular disease or condition, such as DBA. The RPL26 gene has been associated with a specific subtype of DBA known as DBA type 11.

NGS genetic testing can be used to analyze the RPL26 gene for any mutations or variations that may be contributing to the development of DBA in an individual. By identifying specific genetic variations in the RPL26 gene, NGS genetic testing can help in confirming a diagnosis of DBA type 11 and provide valuable information for the management and treatment of the condition. It can also be used for genetic counseling and family planning purposes, as it can determine if there is a risk of passing on the condition to future generations.

Test Name	RPL26 Gene Diamond-Blackfan anemia type 11 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hematology
Doctor	Hematologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for RPL26 Gene Diamond-Blackfan anemia type 11 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RPL26 Gene Diamond-Blackfan anemia type 11 NGS Genetic DNA Test gene RPL26
Test Details	The RPL26 gene is a gene that provides instructions for making a protein called ribosomal protein L26. This protein is a component of the ribosome, which is the cellular machinery responsible for protein synthesis. Diamond-Blackfan anemia (DBA) is a rare genetic disorder characterized by a failure of the bone marrow to produce red blood cells. It is usually diagnosed in infancy or early childhood and can lead to symptoms such as pale skin, fatigue, and an increased risk of infections. NGS (Next-Generation Sequencing) genetic testing is a technique that allows for the simultaneous sequencing of multiple genes or even the entire genome. It can be used to identify genetic mutations or variations that may be associated with a particular disease or condition, such as DBA. The RPL26 gene has been associated with a specific subtype of DBA known as DBA type 11. NGS genetic testing can be used to analyze the RPL26 gene for any mutations or variations that may be contributing to the development of DBA in an individual. By identifying specific genetic variations in the RPL26 gene, NGS genetic testing can help in confirming a diagnosis of DBA type 11 and provide valuable information for the management and treatment of the condition. It can also be used for genetic counseling and family planning purposes, as it can determine if there is a risk of passing on the condition to future generations.